XML 71 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company's assets that are measured at fair value on a recurring basis consist of the following:
 
 
 
Fair Value Measurements at Reporting Date Using
As of September 30, 2019
Fair Value
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
Available-for-sale debt securities:
 
 
 
 
 
Corporate bonds
$
3,907.0

 

 
$
3,907.0

U.S. government and government agency obligations
66.0

 

 
66.0

Sovereign bonds
27.4

 

 
27.4

Commercial paper
108.8

 

 
108.8

Certificates of deposit
66.8

 

 
66.8

Equity securities (unrestricted)
46.9

 
$
46.9

 

Equity securities (restricted)
382.8

 
49.3

 
333.5

 
$
4,605.7

 
$
96.2

 
$
4,509.5

 
 
 
 
 
 
As of December 31, 2018
 
 
 
 
 
Available-for-sale debt securities:
 
 
 
 
 
Corporate bonds
$
2,718.4

 

 
$
2,718.4

U.S. government and government agency obligations
109.4

 

 
109.4

Sovereign bonds
7.6

 

 
7.6

Commercial paper
113.8

 

 
113.8

Certificates of deposit
60.0

 

 
60.0

Equity securities (unrestricted)
43.6

 
$
43.6

 

Equity securities (restricted)
44.4

 

 
44.4

 
$
3,097.2

 
$
43.6

 
$
3,053.6


Marketable securities included in Level 2 are valued using quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or model-based valuations in which significant inputs used are observable. The Company considers market liquidity in determining the fair value for these securities.
The Company held certain restricted equity securities as of September 30, 2019, including its investment in Alnylam (see Note 3), which are subject to transfer restrictions that expire at various dates through 2023.
During the three and nine months ended September 30, 2019, we recorded $15.7 million of net unrealized gains and $58.4 million of net unrealized losses, respectively, on equity securities in Other income (expense), net. During the three and nine months ended September 30, 2018, we recorded $4.9 million of net unrealized losses and $21.0 million of net unrealized gains, respectively, on equity securities in Other income (expense), net.
As of September 30, 2019 and December 31, 2018, the Company had $43.1 million and $45.5 million, respectively, in equity investments that do not have a readily determinable fair value. These investments are recorded within Other noncurrent assets.